ArticleBritish journal of cancer1999

GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells.

J A Marchal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.